Comments: IL HB2531 | 2017-2018 | 100th General Assembly

Bill Title: Amends the Illinois Food, Drug and Cosmetic Act. Deletes provisions requiring manufacturers to provide the Director of Public Health with a notification containing product technical bioequivalence information no later than 60 days prior to specified generic drug product substitution. Effective immediately.

Spectrum: Partisan Bill (Republican 3-0)

Status: (Passed) 2017-08-11 - Public Act . . . . . . . . . 100-0065 [HB2531 Detail]

Text: Latest bill text (Chaptered) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2017 Illinois HB2531 at this time.

Social Comments on IL HB2531

feedback